Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Impact of Guselkumab Versus Placebo and Adalimumab...
Conference

Impact of Guselkumab Versus Placebo and Adalimumab on Patient Reported Outcomes in Patients with and without Psoriatic Arthritis in a Phase 3 Pivotal Psoriasis Study

Authors

Puig L; Hang C; Vender R; Song M; You Y; Shen Y-K; Foley P

Volume

70

Publisher

WILEY

Publication Date

9 2018

Name of conference

Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-for-Rheumatology-Health-Professionals (ARHP)

Conference place

IL, Chicago

Conference start date

October 19, 2018

Conference end date

October 24, 2018

Conference proceedings

ARTHRITIS & RHEUMATOLOGY

ISSN

2326-5191